Functionalized Rhodium Nanoparticles as Antimicrobial Agents for Treatment of Drug‐Resistant Skin and Soft Tissue Infections

Abstract

AbstractSkin and soft tissue infections (SSTIs) are among the most common bacterial infections reported in outpatients. Drug‐resistant bacteria are the major cause of treatment failure and increased mortality rate in patients with SSTIs, posing significant challenges to human health. In this study, new‐generation rhodium nanoplates (RhNPs) and glycol chitosan‐ and polydopamine‐functionalized RhNPs (Rh@GCS) are developed for the treatment of drug‐resistant SSTIs. RhNPs exhibited favorable antibacterial activity against methicillin‐resistant Staphylococcus aureus (MRSA) and Ag‐resistant MRSA. The modified Rh@GCS exhibited enhanced antibacterial activity and can directly kill various drug‐resistant bacteria by increasing the permeability of cell membranes, including gram‐positive MRSA and gram‐negative multidrug‐resistant Escherichia coli (E.coli) and Pseudomonas aeruginosa (PA). Moreover, Rh@GCS effectively inhibited bacterial growth and promoted the healing of skin lesions in MRSA‐induced SSTI mouse models. These results suggest that Rh@GCS is a promising nonantibiotic antimicrobial agent for the treatment of drug‐resistant SSTIs.